CASNumber220127-57-1
EmpiricalFormula(HillNotation)C29H31N7O·CH4O3S
MolecularWeight589.71
Properties:
| RelatedCategories | AnalyticalStandards,Analytical/Chromatography,EPStandards,EPStandardsI-K,Pharmacopeia&MetrologicalInstitutesStandards |
Description:
Generaldescription
ThisproductisprovidedasdeliveredandspecifiedbytheissuingPharmacopoeia.Allinformationprovidedinsupportofthisproduct,includingSDSandanyproductinformationleafletshavebeendevelopedandissuedundertheAuthorityoftheissuingPharmacopoeia.
ForfurtherinformationandsupportpleasegotothewebsiteoftheissuingPharmacopoeia
.
OtherNotes
Salesrestrictionsmayapply.
Packaging
Unitquantity:120mg.Subjecttochange.TheproductisdeliveredassuppliedbytheissuingPharmacopoeia.Forthecurrentunitquantity,pleasevisittheEDQMreferencesubstancecatalogue
.
Biochem/physiolActions
Imatinibmesylateisatyrosinekinaseinhibitorwithantineoplasticactivity.ImatinibisapotentinhibitoroftheBcr-Ablkinaseencodedbythebcr-abloncogeneaswellasreceptortyrosinekinasesencodedbyc-kitandplatelet-derivedgrowthfactorreceptor(PDGFR)oncogenes.ImatinibmesylateinhibitionofBcr-AbltyrosinekinasecreatedbythePhiladelphiachromosomeabnormalityfoundinCMLdecreasesproliferationandenhancesapoptosisinleukemiasCMLandALL.Inhibitionofc-kittyrosineactivityinhibitsmast-cellandcellularproliferationinthosediseasesoverexpressingc-kitsuchasgastrointestinalstromaltumor(GIST).
Safety:
GHS07
